FDA Issues Warnings for Osteoporosis Drug Fosamax

The FDA has released numerous warnings about the bisphosphonate osteoporosis drug Fosamax. While some of these warnings pertain to mild or moderate side effects, others inform patients of the dangers of thigh fractures and osteonecrosis of the jaw, two of the most serious side effects associated with the drug. Patients who were not made aware of the side effects noted in FDA warnings may have grounds for a lawsuit.

If you have been injured by a thigh fracture, osteonecrosis of the jaw, or any other Fosamax side effects, speak with an attorney in your area.

FDA Warnings

Over the years, more and more side effects have reportedly been linked with Fosamax, as problems have become more prevalent and widely reported. Consequently, the FDA has released new warnings for those taking the drug as these potential side effects become more common. According to the FDA, the drug carries a risk of the following side effects:

• Osteonecrosis of the jaw, or dead jaw: dead jaw bone which can lead to pain, disfigurement, and lifelong complications
• Femur or thigh fractures: fractures of the thigh bone which are atypical even for osteoporosis patients
• Irritation of the esophagus and stomach, sometimes leading to heartburn or ulcers
• Extreme muscle or bone pain

The FDA warnings apply to a number of other bisphosphonates. These drugs are similar in their active ingredients and makeup and include generic versions. FDA warnings apply to:

• Fosamax
• Fosamax plus D
• Actonel and Actonel with Calcium
• Atelvia
• Boniva

Filing a Lawsuit

Just because there are FDA warnings concerning side effects, does not mean that individuals injured by Fosamax have no legal recourse. If the manufacturer, Merck & Co., failed to warn patients about the side effects of its products, individuals who have experienced side effects may be able to recover compensation for their injuries through a lawsuit.

Before commenting, please review our comment policy.